SHANGHAI, April 1, 2021 /PRNewswire/ -- Molecular Data Inc.
("Molecular Data" or the "Company") (Nasdaq: MKD), a leading
technology-driven platform in China's chemical industry, announced that it
has signed a cooperation agreement with Dalian Lianhua
Chemical Co., Ltd. ("Dalian Lianhua"), a leading manufacturer in
the subdivision field of boric acid compounds in China. In the future, the two companies will
combine the strengths of both parties to help the rapid development
of R&D in domestic pharmaceutical companies and the drug
synthesis industries.
Molecular Data is already using digital tools including big
data and neuron network to achieve the intelligent optimization of
the industry supply chain. The selective use of Blockchain
including Blockchain Oracle, decentralized oracle network will
empower the scientific research progress of domestic pharmaceutical
companies.
With the signing of the cooperation agreement, this will put
hundreds of products such as boric acids, reagents and chiral
compounds produced by Dalian Lianhua, on the Molecular
Data e-commerce platform.
Lianhua and Molecular Data intends to jointly serve a
wide range of pharmaceutical companies and biotechnology,
agro-chemical and special chemical companies globally.
As the two parties work together, they can yield better
intelligent digital systems and create one-stop e-commerce
platforms to provide industry customers with higher quality
Compounds and intermediates, This will not only help better new
drug R&D, it will also improve industry R&D efficiency, and
help companies improve their scientific research capabilities.
Dalian Lianhua Chemical Co., Ltd. was established in 2004. With
hundreds of pharmaceutical chemicals developed and industrialized,
their main products dominate the international market.
It is a professional manufacturer of organic boric acid products
and chiral products, and an industry-recognized supplier of key raw
materials for pharmaceuticals and new materials. The company
focuses on technological innovation and the industrialization of
core products and has independent intellectual property rights, and
has applied for numerous national patents.
About Molecular Data Inc.
Molecular Data Inc. is a leading technology-driven platform in
China's chemical industry,
connecting participants along the chemical value chain through
integrated solutions. The Company delivers e-commerce solutions,
financial solutions, warehousing and logistics solutions, and SaaS
suite that are intended to solve pain points for participants in
the traditional chemical industry. Built upon a comprehensive
knowledge engine and artificial intelligence (AI) capabilities, the
Company's e-commerce solutions are mainly offered through its
online platform, consisting of molbase.com,
molbase.cn, Moku Data WeChat account, Chemical Community APP
and other ancillary platforms.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "aims," "future," "intends,"
"plans," "believes," "estimates," "confident," "potential,"
"continue" or other similar expressions. Among other things, the
quotations from management in this announcement, as well as the
Company's strategic and operational plans, contain forward-looking
statements. The Company may also make written or oral
forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Statements that are not historical facts, including
but not limited to statements about the Company's beliefs and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties, and a variety
of factors could cause actual results to differ materially from
those contained in any forward-looking statement, including but not
limited to the following: the Company's goals and strategies; the
Company's future business development, results of operations and
financial condition; the expected growth of the chemical market;
the Company's ability to monetize the user base; fluctuations in
general economic and business conditions in China; the potential impact of the COVID-19 to
the Company's business operations and the economy in China and elsewhere generally; and assumptions
underlying or related to any of the foregoing. Further information
regarding these and other risks is included in the Company's
filings with the Securities and Exchange Commission. All
information provided in this press release and in the attachments
is as of the date of the press release, and the Company undertakes
no duty to update such information, except as required under
applicable law.
View original
content:http://www.prnewswire.com/news-releases/molecular-data-inc-intends-to-further-upgrade-its-digital-tools-using-blockchain-301260444.html
SOURCE Molecular Data Inc.